Search results
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 11 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 12 hours agoThe Food and Drug Administration just signed off on Tivdak, an antibody drug conjugate for patients...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoResults showed a statistically significant overall survival (OS) rate, with a median OS of 11.5...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 14 hours agoOxbryta was added with the October 2022 acquisition of Global Blood Therapeutics. Oncology Pfizer’s...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 hours agoWe are pleased with the excellence we have been able to achieve in both integration and commercial execution. With a strong mix of Pfizer and Seagen...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 9 hours agoCEO Albert Bourla has made several moves to bolster the pipeline, including the $43 billion Seagen...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 12 hours agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 16 hours agoThe revenue from legacy Seagen contributed significantly to the non-COVID portfolio growth. Notable...
Pfizer Profits Drop On Lower Covid-19 Product Sales
International Business Times· 17 hours agoThe drugmaker pointed to increased sales of oncology products, in part driven by the acquisition of Seagen, which was completed in December. Other...
